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ABSTRACT:  This paper reports the first examples of Suzuki-
Miyaura cross-couplings involving aryl- and 
naphthylphosphonate-based boronate esters as the nucleophilic 
partner. A systematic comparison of the performance of biaryl-
like KITPHOS and XPHOS-based systems revealed that between 
them an electronically and sterically diverse range of substrates 
can be coupled with remarkable efficiency to afford high yields of 
the corresponding biaryl and heterobiaryl monophosphonates. The 
use of an aryl- and naphthylphosphonate-based boronate ester as 
the coupling partner presents an alternative and potentially 
complementary pathway to existing couplings in which the aryl- 
or naphthylphosphonate unit is typically introduced as the 
electrophile. The potential advantages associated with the use of 
this new class of coupling partner was clearly demonstrated by the 
palladium-catalyzed reaction between diethyl [2-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]phosphonate and 1-
bromo-2-methoxynaphthalene which gave the corresponding 
biaryl monophosphonate in 56% yield, a  marked improvement on 
the 6% yield obtained from the reaction between 2-methoxy-1-
naphthylboronic acid and diethyl (2-bromophenyl)phosphonate 
with the same catalyst under the same conditions. The potential 
utility of this new coupling combination was demonstrated by 
reducing one of the products, 2-methoxy-1-(2ʹ-
diethoxyphosphorylphenyl)naphthylene, to the corresponding 
primary phosphine, which was subsequently converted into a 
diastereoisomeric mixture of the R,R-hexane-2,5-diol-derived 
phospholane in reasonable yield.   
INTRODUCTION 
Recent years have witnessed an escalating interest in the 
synthesis and elaboration of functional biaryl monophosphonates 
as this motif appears in a host of important bioactive compounds 
and P-based ligands.1 Indeed, since their introduction, biaryl 
monophosphines have evolved into a highly versatile and 
powerful class of ligand for a host of transition metal-catalyzed 
transformations.2-10 While these ligands have been prepared by 
modifying an existing biaryl unit,11 Buchwald’s  one-pot protocol, 
based on addition of an aryl Grignard to an in situ generated 
benzyne followed by trapping of the resulting intermediate with a 
chlorophosphine, is arguably the method of choice as it combines 
elegance and efficiency with modularity and versatility.12 More 
recently, the biaryl framework of monophosphines have been 
constructed via cycloaddition reactions involving 1-
alkynylphosphine oxides and sulphides including microwave-
based Diels-Alder cycloaddition-extrusion between a 1-
alkynylphosphine oxide and a diene,13 rhodium-catalysed [2+2+2] 
cycloaddition of a tethered diyne with a 1-alkynylphosphine oxide 
or sulphide,14 [4+2] cycloaddition between anthracene and a 1-
alkynylphosphine oxide15 and palladium-catalysed annulation of 
1-alkynylphosphine sulphides with 2-iodoanilines.16 
Alternatively, the biaryl motif of monophosphine oxides17 and 
phosphonates18 have also been prepared directly via palladium-
catalyzed cross-coupling of aryl boronic acids with aryl bromides 
containing ortho P(O)R2 and P(O)(OR)2 groups, respectively, and 
while the need to reduce the resulting phosphine oxide restricts 
the range of accessible phosphino groups, phosphonates are 
versatile and can be transformed into a variety of P-based ligands. 
Although the overwhelming majority of biaryl monophosphines 
have been developed for use in achiral transformations, axially 
chiral biaryl monophosphines have been identified as the ligand of 
choice for a select number of asymmetric reactions including 
Suzuki-Miyaura cross-coupling,18 -arylation/vinylation of 
carbonyl enolates,19 hydrosilylation of olefins20 and 
hydrovinylation.21 These ligands are typically based on either a 
tri- or tetrasubstituted biaryl unit which often contains an 
additional heteroatom donor such as -NR2 (KenPhos) or -OMe 
(MOP) at the 2ʹ-position. While these ligands are commonly 
prepared from enantiopure biaryl electrophiles via metal-
catalyzed phosphination,22 Buchwald18a,b and others18c-g have 
demonstrated that axially chiral biaryl monophosphonates can 
also be obtained in excellent yield and high ee via asymmetric 
palladium-catalyzed coupling of aryl halides bearing an ortho 
phosphonate group with substituted aryl boronic acids; the 
resulting phosphonates are ideal precursors for diversification into 
phosphines, phosphinites and phospholanes for use in catalysis. 
More recently chiral biaryl and heterobiaryl monophosphonates 
have been prepared in high enantioselectivity via 
rhodium/BINAP-catalyzed [2+2+2] cycloaddition of symmetrical 
diynes with 2-substituted naphthylethynyl phosphonates14a and 
QUINAP has been synthesized via an elegant and highly efficient 
dynamic kinetic resolution involving an atroposelective P-C 
coupling.23   
 Given the justifiable status of the biaryl architecture as a 
privileged scaffold,24 there is still considerable interest in 
developing alternative approaches to constructing this motif. As 
part of an on-going programme to develop new ligands for 
palladium-catalyzed C-C and C-heteroatom bond formation we 
initiated a study to target novel cross-coupling partners and chose 
to investigate aryl/naphthyl boronate esters substituted with an 
ortho phosphonate group on the basis that they represent a new 
class of nucleophilic coupling partner that could provide access to 
architecturally important achiral and axially chiral biaryl and 
heterobiaryl ligands. Herein, we disclose the first examples of 
Suzuki-Miyaura couplings involving aryl and 
naphthylphosphonate-based boronate esters as the nucleophilic 
partner (Equation 1) and that good to excellent yields of tropos 
and atropos biaryl and heterobiaryl monophosphonates can be 
obtained using relatively low catalyst loadings. The use of 
arylphosphonate-based boronate esters as the nucleophilic 
coupling partner has not previously been reported and could 
eventually complement/extend existing approaches in which the 
phosphonate is introduced as the electrophile18 (Equation 2).   
 
 
 
RESULTS AND DISCUSSION 
This project was initiated to develop the use of aryl- and 
naphthylphosphonate-based boronate esters as nucleophilic 
partners in Suzuki-Miyaura cross coupling reactions and to 
undertake a systematic comparison of the performance of our 
KITPHOS monophosphines (1a, R = Cy; 1b, R = Ph) against their 
biaryl-based counterpart XPHOS. The associated precatalysts 2a-
c (L = 1a, 2a; L = 1b, 2b; L = XPHOS, 2c) required for this study 
were prepared in a straightforward manner by reaction of the 
corresponding phosphine with the chloride bridged dimer [Pd{2-
N2ʹ,C1-2-(2ʹ-NH2C6H4)C6H4}(-Cl)]2 in a 1/1 mixture of acetone 
and dichloromethane (Scheme 1).25  
 
 
Scheme 1. Synthesis of KITPHOS and XPHOS-based 
precatalysts 2a-c.  
 
One-component precatalysts of this type have recently been 
introduced and promoted by Buchwald as an  extremely 
convenient and efficient source of L1Pd(0) as they are air- and 
moisture-stable and readily undergo spontaneous and quantitative 
reductive elimination of the cyclometalated amine to afford 9H-
carbazole upon treatment with base and, in this regard, are  
markedly more efficient than generating the catalyst in situ from 
either a source of Pd(0) such as Pd2(dba)3 or from Pd(OAc)2 and 
excess phosphine.26 Precatalyst 2a-c were purified by column 
chromatography and characterized by a combination of the usual 
spectroscopic and analytical techniques. Even though the 
spectroscopic properties of 2a-b are similar to those reported for 
2c27 and therefore fully consistent with the proposed formulation, 
a single-crystal X-ray analysis of 2b was also undertaken to 
compare the key structural features with those of related 
complexes; a perspective view of the molecular structure is shown 
in Figure 1. The palladium center adopts a slightly distorted 
square planar geometry with the phosphine located trans to the 
amine due to the high trans influence of the strongly -donating 
metalated aromatic ring28 while the key Pd(1)-P(1), Pd(1)-N(1), 
Pd(1)-C(1) and Pd(1)-Cl(1) bond lengths are all similar to those in 
[Pd{2-N2ʹ,C1-2-(2ʹ-NH2C6H4)C6H4}(Cl)(L)] (L = SPHOS, 
XPHOS and dihydro-KITPHOS).27,29-30  
 
 
Figure 1. Molecular structure of [Pd{2-N2ʹ,C1-2-(2ʹ-
NH2C6H4)C6H4}Cl{11-(diphenylphosphino)-12-phenyl-9,10-
dihydro-9,10-ethenoanthracene}] (2b). Hydrogen atoms have 
been omitted for clarity. Ellipsoids are drawn at the 50% 
probability level.    
 
With the aim of developing complementary pathways to 
biaryl monophosphonates, we began our study by investigating 
the cross-coupling between diethyl (2-bromophenyl)phosphonate 
3 and a selection of commercially available aryl boronic acids, 
full details of which are presented in Table 1. Our preliminary 
comparison and optimization focused on the coupling between 3 
and benzene boronic acid using 0.1 mol% of precatalysts 2a-c and 
identified K3PO4 to be the optimum base and THF/H2O (2:1, v/v) 
as the solvent of choice. Under these conditions catalyst generated 
from 2a-c each gave 4a in good yield with XPHOS-based 2c 
proving to be more efficient than its KITPHOS counterparts 2a 
and 2b (entry 1-3). As such, each substrate combination in this 
study has been conducted with KITPHOS-based precatalysts 2a-b 
as well as 2c in order to undertake a systematic, thorough and 
meaningful comparison. Although good conversions were also 
obtained with 0.1 mol% 2a in dry THF, under otherwise identical 
conditions, the presence of added water resulted in consistently 
higher yields.31 The choice of base and solvent also proved crucial 
to achieving good conversions; K3PO4 was most effective for 
 reactions conducted in toluene, while KF and K3PO4 were both 
effective bases for reactions conducted in THF, DME and toluene, 
K2CO3 was more effective in toluene than THF and other bases 
such as alkali metal acetates and alkoxides were markedly less 
effective in all solvents.   
 
Table 1. Palladium-Catalyzed Suzuki-Miyaura Coupling of 
Diethyl (2-bromophenyl)phosphonate with Aryl Boronic 
Acidsa 
 
 Ar-B(OH)2 Precat 
(mol%) 
Time 
(min) 
Product Yield 
(%)b 
1  
 
2a/0.1 15 4a 83 
2 2b/0.1 15 4a 68 
3 2c/0.1 15 4a 99 
4  
 
2a/0.1 15 4b 92 
5 2b/0.1 15 4b 70 
6 2c/0.1 15 4b 45 
7  
 
2a/0.1 15 4c 98 
8 2b/0.1 15 4c 68 
9 2c/0.5 15 4c 63 
10 
 
 
2a/0.5 30 4d 97 
11 2b/0.5 30 4d 34 
12 2c/0.5 30 4d 42 
13 
 
2a/0.5 30 4e 98 
14 2b/0.5 180 4e 78 
15 2c/0.5 30 4e 24 
16 
 
2a/0.5 960 4f 6 
17 
18 
2b/0.5 
2c/0.5 
960 
960 
4f 
4f 
0 
0 
aReaction conditions: 0.4 mmol of 3, 0.6 mmol  of boronic acid, 0.8 mmol 
of K3PO4, 0.1-0.5 mol% of 2a-c, 2 mL THF, 1 mL water, 70 ºC. 
bIsolated 
yield after purification by column chromatography. Average of three runs.       
 
In contrast to phenyl boronic acid, KITPHOS derived 2a 
formed a more efficient catalyst than its XPHOS counterpart for 
the coupling of substituted aryl boronic acids including 4-
methoxyphenyl boronic acid (entries 4-6) and 4-chlorophenyl 
boronic acid (entries 7-9). For example, 0.1 mol% of 2a gave 4b 
and 4c in 96% and 98% yield, respectively, after 30 min while the 
corresponding yields of 45% and 63%, respectively, obtained with 
2c were somewhat lower. The same trend in performance also 
extended to the sterically more challenging 2-methoxyphenyl 
boronic acid and o-tolyl boronic acid (entries 10-15) as 0.5 mol% 
of 2a gave 4d and 4e in 97% and 98% yield, respectively, after 
only 30 min, which were a significant and marked improvement 
on the corresponding yields of 42% and 24% obtained with its 
XPHOS counterpart. Interestingly, for each aryl boronic acid 
tested, reasonable to good yields of product were also obtained 
with precatalyst 2b, which was somewhat surprising considering 
the triaryl-like nature of the monophosphine. However, 
disappointingly low yields were obtained for the sterically more 
challenging combination of 2-methoxy-1-naphthylboronic acid 
and diethyl-(2-bromophenyl)phosphonate even with 2 mol% 2a-c, 
which revealed the limitation of these palladacyclic precatalysts 
for this coupling (entries 16-18).  
Encouraged by the efficacy of 2a-c for the cross-coupling of 
an arylphosphonate-based electrophile, the study was extended to 
explore the coupling of aryl and naphthylphosphonate-derived 
boronate esters as the nucleophilic partner on the basis that this 
was an entirely new reagent that could further broaden and extend 
the range of accessible biaryl and heterobiaryl 
monophosphonates. Phenyl and naphthyl pinacol boronate esters 
5a and 5b, respectively, were prepared in good yield via the 
palladium-catalyzed borylation of diethyl (2-
bromophenyl)phosphonate and diethyl (1-bromonaphthalen-2-
yl)phosphonate, respectively, with B2(pin)2 in dioxane at 90 °C 
for 16 h using 5 mol% PdCl2(dppf) as catalyst (Equation 3).
32 
While 5a-b could also be prepared by reaction of the derived 
Grignard reagent with B(OMe)3 followed by alcoholysis with 
pinacol the yields were slightly lower for this multistep sequence.   
 
An additional brief optimization study using bromobenzene 
and 5a as the benchmark combination with 0.5 mol% of 
precatalyst 2a, revealed that the highest conversions were also 
obtained in THF/water with K3PO4 as base at 70 ºC whereas those 
obtained in DME, dry THF or toluene with the same base were 
markedly lower. A survey of the base revealed that good 
conversions could also be obtained in THF/H2O with Cs2CO3 
while Na2CO3, KF and KOAc all gave poor conversions; full 
details are provided in Table S1 of the supporting information. As 
catalyst generated from XPHOS-based 2c also gave 4a in high 
yield (Table 2, entries 1-3), precatalysts 2a-c were used to explore 
the range of substrate combinations and undertake comparative 
catalyst testing. Under these optimum conditions, catalyst 
generated from 0.5-2.0 mol% of 2a-c efficiently promoted the 
coupling between 5a and a range of electron-rich and electron-
poor aryl halides as well as heteroaryl halides to give high yields 
in relatively short reaction times. The results in Table 2 show that 
(i) catalyst based on 2a was consistently more efficient than its 
diphenylphosphino counterpart 2b across the entire set of 
substrates tested, (ii) catalyst generated from 2a either competed 
with or outperformed its XPHOS counterpart 2c, albeit by a 
relatively small margin in some cases, and (iii) higher catalyst 
loadings and longer reaction times were required compared with 
the corresponding couplings involving 3. For example, catalyst 
generated from 0.5 mol% of 2a coupled 4-bromoanisole with 5a 
to afford 4b in 66% yield after 60 min (Table 2, entry 4). whereas 
the same product was obtained in 92% yield from the reaction 
between 3 and 4-methoxyphenyl boronic acid after only 15 min 
using 0.1 mol% of the same precatalyst (Table 1, entry 4). 
Sterically hindered 2-substituted aryl bromides required longer 
reaction times to give good yields (Table 2, entries 10-21) and a 
comparison of catalyst efficacy across this narrow range of 
substrates underpins the competitive performance of KITPHOS 
monophosphines against their well-established biaryl 
counterparts. Precatalysts 2a and 2c both effectively promoted the 
coupling of 2-bromopyridine and 2-bromopyrimidine with 5a to 
give the corresponding heterobiaryl monophosphonates 4h and 4i, 
respectively, in good yields after 4 h (Table 2, entries 22-27); in 
both cases KITPHOS-precatalyst 2a outperformed 2b and 2c. In 
contrast, 2a and 2c gave comparable yields of 4j from the reaction 
 between 5-bromopyrimidine and 5a after 2h at 70 ºC (Table 2, 
entries 28-30).   
 
Table 2. Palladium-Catalyzed Suzuki-Miyaura Coupling of 
Aryl Halides with 5a using Precatalysts 2a–ca 
 
 Ar-B(OH)2 Precat 
(mol%) 
Time 
(h) 
Product Yield 
(%)b 
1  
 
2a/0.5 1 4a 69 
2 2b/0.5 1 4a 44 
3 2c/0.5 1 4a 77 
4 
 
2a/0.5 1 4b 66 
5 2b/0.5 1 4b 60 
6  2c/0.5 1 4b 59 
7 
 
2a/0.5 1 4c 90 
8 2b/0.5 1 4c 70 
9  2c/0.5 1 4c 62 
10 
 
2a/0.5 4 4d 60 
11 
12 
2b/0.5 
2c/0.5 
4 
4 
4d 
4d 
30 
76 
13 
 
2a/0.5 2 4e 91 
14 2b/0.5 2 4e 61 
15  2c/0.5 2 4e 83 
16 
 
2a/2.0 16 4f 56 
17 
18 
2b/2.0 
2c/2.0 
16 
16 
4f 
4f 
0 
0 
19 
 
2a/0.5 16 4g 40 
20 
21 
2b/0.5 
2c/0.5 
16 
16 
4g 
4g 
0 
49 
22 
 
2a/0.5 4 4h 91 
23 2b/0.5 4 4h 62 
24  2c/0.5 4 4h 64 
25 
 
2a/0.5 4 4i 91 
26 2b/0.5 4 4i 24 
27  2c/0.5 4 4i 81 
28 
 
2a/0.5 2 4j 50 
29 2b/0.5 2 4j 30 
30  
 
2c/0.5 2 4j 49 
31 
32 
2a/0.5 
2c/0.5 
16 
16 
4k 
4k 
41 
81 
aReaction conditions: 0.2 mmol of Ar-X, 0.3 mmol  5a, 0.4 mmol of 
K3PO4, 0.5 or 2 mol% 2a-c, 2 mL THF, 1 mL water, 70 ºC. 
bIsolated yield 
after purification by column chromatography. Average of three runs.   
While 2a formed a highly efficient catalyst for the coupling of 
aryl and heteroaryl bromides, its XPHOS counterpart proved to be 
the catalyst of choice to couple 4-chloroacetophenone with 5a as 
the yield of 81% obtained after 16 h at 70 ºC with 0.5 mol% of 2c 
was markedly higher than that of 41% obtained with 2a in the 
same time (Table 2, entries 31-32). With the intention of applying 
this substrate combination to the synthesis of axially chiral 
atropisomeric biaryl monophosphonates for further diversification 
into new biaryl ligands the coupling between 1-bromo-2-
methoxynaphthalene and boronate ester 5a was also investigated. 
Gratifyingly, phosphonate 4f was obtained in 56% yield after 16 h 
at 70 ºC with 2 mol% of palladacycle 2a (Table 2, entry 16) and 
even though the yield did not increase with longer reaction times 
it is a substantial and marked improvement on the corresponding 
coupling between 3 and 2-methoxy-1-naphthylboronic acid (Table 
1, entry 16-18); this promising result underpins the potential 
benefits of employing arylphosphonate-based boronate esters and 
their acids as the nucleophilic partner in Suzuki-Miyaura cross 
couplings.  
Based on the promising results obtained with 5a and 
reasoning that it would be both instructive and informative to 
have access to an isomeric ligand pair with the phosphonate group 
located on either the naphthyl fragment or the phenyl ring for 
comparative catalyst testing the coupling of naphthylphosphonate 
boronate ester 5b with a series of aryl and heteroaryl bromides 
was also examined, details of which are presented in Table 3. This 
phase of the study focused on the use of precatalysts 2a and 2c as 
they gave the most promising yields for sterically challenging 
substrate combinations in Table 2. Under the conditions described 
above, good yields were obtained with electron rich, electron 
poor, sterically hindered aryl as well as heteroaryl electrophilic 
partners. For example, 2a and 2c formed highly efficient catalysts 
for the reaction between 5b and 4-bromoanisole or 4-chloro 
bromobenzene (Table 3, entries 1-4), interestingly, the latter 
reaction occurred chemoselectively to afford 4m with no evidence 
for activation of the chloride, as evidence by analysis of the crude 
reaction mixture as well as the purified product by high resolution 
LCMS; a minor contaminant (˂5%) has been identified by NMR 
spectroscopy and HRMS as diethyl naphthalen-2-ylphosphonate, 
the product of protodeboronation. Sterically hindered and 
heteroaryl coupling partners typically required a higher catalyst 
loading and longer reaction time to reach good conversions. For 
example, 2 mol% of palladacycle 2a coupled 2-bromotoluene and 
2-bromoanisole with 5b to give the corresponding atropisomeric 
monophosphonates 4n and 4o in 76% and 77% yield, respectively 
after 16 h at 70 ºC (Table 3, entries 5 and 7); for comparison 2c 
gave the same products in 42% and 87% yield, respectively, under 
the same conditions (Table 3, entries 6 and 8). Interestingly, the 
coupling between 5b and 2-bromoanisole to give 4o occurs more 
efficiently than the corresponding ‘isomeric coupling’ between 2-
methoxy-1-bromonaphthalene and phosphonate 5a, which affords 
4f in 56% yield. Finally, precatalyst 2a outperformed its XPHOS 
counterpart for the coupling between 2-bromopyridine and 5b due 
to facile competing protodeboronation which presumably 
becomes more significant in the presence of a less efficient 
catalyst.33 In this regard, protodeboration was identified as the 
only competing pathway for reactions involving 5b, which 
became more significant for substrate combinations that required 
long reaction times. For instance, while the cross coupling 
between 5b and either 4-bromoanisole or 4-bromochlorobenzene 
resulted in 1-4% protodeboronation this increased to 19% and 
21% for the corresponding reactions involving 2-bromotoluene 
and 2-bromoanisole, respectively, with 2a and 2c giving the same 
level of protodeboronation for both substrate combinations. In 
contrast, the extent of protodeboronation for the reaction between 
2-bromopyridine and 5b was catalyst dependent and much more 
rapid for 2c which gave 73% conversion to diethyl naphthalen-2-
ylphosphonate compared to only 21% with 2a.    
Thus, in terms of ligand synthesis 5b appears to be a practical 
coupling partner as high yields of the corresponding atropos 
 biaryl/heterobiaryl monophosphonates can be obtained in short 
reaction times under mild conditions. As monophosphonates 4n 
and 4o are ideal precursors to chiral monophosphines future 
endeavours will be directed towards developing an asymmetric 
version of this coupling using KenPHOS and electron-rich MOP-
type monophosphines as lead ligands.18a-g  
 
Table 3. Palladium-Catalyzed Suzuki-Miyaura Coupling of 
Aryl Bromides with 5b using Precatalysts 2a and 2ca  
 
 
 Ar-B(OH)2 Precat 
(mol%) 
Time 
(h) 
Product Yield 
(%)b 
1 
 
2a/0.5 2 4l 68 
2 2c/0.5 2 4l 53 
3 
 
2a/0.5 2 4m 81
c 
4 2c/0.5 2 4m 89
c 
5 
 
2a/2.0 16 4n 76 
6 2c/2.0 16 4n 42 
7 
 
2a/2.0 16 4o 77 
8 2c/2.0 16 4o 87 
9 
10  
2a/1.0 
2c/1.0 
16 
16 
4p 
4p 
58 
25 
aReaction conditions: 0.2 mmol of Ar-Br, 0.3 mmol of 5b, 0.4 mmol of 
K3PO4, 0.5 or 2 mol% of 2a or 2c, 2 mL THF, 1 mL water, 70 ºC.  
bIsolated yield after purification by column chromatography. Average of 
three runs. cYield adjusted to account for protodeboronation.      
 
As a proof of principle exercise before applying these new 
coupling partners to the synthesis of monophosphines, rac-4f was 
first reduced with LiAlH4 to afford the corresponding primary 
phosphine as a white air-stable solid in quantitative yield. The 31P 
NMR spectrum of 6 contains a triplet with a characteristically 
large 1JPH of 204 Hz while the associated diastereotopic protons 
appear as a pair of doublets at  3.54 and 3.59 ppm in the 1H 
NMR spectrum. As primary phosphines are ideal precursors to 
phospholane-based ligands, 6 was reacted with the cyclic sulphate 
derived from R,R-hexane-2,5-diol by stepwise treatment with n-
BuLi following previously reported procedures34 to afford a 1:1 
mixture of aR,R,R-7 and aS,R,R-7 in 32% yield, after protection 
as its borane adduct (Scheme 2). Although moderate, this yield is 
a marked improvement on that reported for the closely related 
binaphthyl-based monophospholane 2-phospholano-2ʹ-methoxy-
1,1ʹ-binaphthyl.18d       
 
 
 
Scheme 2. Synthesis of phospholane aR,R,R-7 and aS,R,R-7 by 
reduction of rac-4f. 
CONCLUSION  
In conclusion, the first examples of aryl and 
naphthylphosphonate-derived boronate esters have been prepared, 
their use as nucleophilic coupling partners for the palladium-
catalysed Suzuki-Miyaura cross-coupling with a range of aryl and 
heteroaryl bromides investigated and a comparison with the 
corresponding mutually complementary coupling between aryl 
halides bearing an ortho phosphonate and aryl or naphthylboronic 
acids undertaken. Regardless of the source of aryl or 
naphthylphosphonate (i.e. nucleophile or electrophile) good yields 
of the corresponding biaryl and heterobiaryl monophosphonates 
were obtained with Buchwald-type single source KITPHOS and 
XPHOS precatalysts. Gratifyingly, precatalyst 2a, based on 
dicyclohexylphosphino KITPHOS monophosphine 1a, 
outperformed its XPHOS counterpart 1c for several substrate 
combinations. Taken together, this pair of couplings could 
provide complementary pathways to achiral and axially chiral 
biaryl monophosphonates which will enable the substitution 
pattern of the biaryl architecture to be systematically varied and 
heteroatom groups to be introduced and ultimately be developed 
into a practical and valuable tool for the synthesis of ligands as 
well as bioactive molecules based on the biarylphosphonate motif. 
Studies are currently underway to prepare a broader range of aryl 
and naphthylmonophosphonate-based boronate esters in order to 
expand the scope of this coupling sequence, develop, optimise and 
apply an asymmetric version of this coupling across an array of 
aryl and heteroaryl substrate combinations, explore the range of 
accessible achiral and chiral phosphorus-based ligands that can be 
prepared either from the phosphonate or its corresponding 
primary phosphine and extend the phosphonate-based 
nucleophilic partners to zinc, magnesium and lithium reagents.    
 
EXPERIMENTAL SECTION 
General Considerations. All manipulations involving air-
sensitive materials were carried out using standard Schlenk line 
techniques under an atmosphere of nitrogen or argon in oven-
dried glassware. Dichloromethane and chloroform were distilled 
from calcium hydride, THF and toluene from sodium, and hexane 
and diethyl ether from Na/K alloy, under an atmosphere of 
nitrogen. Bis(pinacolato)diboron, 1-bromo-2-iodobenzene and 
diethylphosphite were purchased from commercial suppliers and 
used without further purification. 1-Bromo-2-
methoxynaphthalene,35 2-methoxy-1-naphthylboronic acid,36 
diethyl 1-bromo-2-naphthylphosphonate,18a,b (2S,5S)-2,5-
hexanediol cyclic sulphate,33 KITPHOS monophosphines 1a-
b,15c,d [PdCl2(1,1-bis(diphenylphosphino)ferrocene]
37 [Pd{k2-
N2′,C1-2-(2′-NH2C6H4)C6H4}(-Cl)]2
25a  and [Pd{k2-N2′,C1-2-(2′-
NH2C6H4)C6H4}Cl(XPHOS)]
27b were prepared as previously 
described. 1H, 13C{1H} and 31P{1H} NMR spectra were recorded 
on 500 or 400 MHz instruments. Thin-layer chromatography 
(TLC) was carried out on aluminum sheets pre-coated with silica 
gel 60F 254, and column chromatography was performed using 
Merck Kieselgel 60. Gas chromatography-mass spectrometry was 
performed using a 30 m, 0.25 mm, 0.25m capillary column, 
elemental microanalytical data were obtained from the Newcastle 
University School of Chemistry analytical services unit and 
electrospray ionization mass spectrometry (ESI-MS) was 
performed by the Newcastle University School of Chemistry mass 
spectrometry service.  
 
Synthesis of [Pd{2-N2′,C1-2-(2′-NH2C6H4)C6H4}Cl{11-
(dicyclohexylphosphino)-12-phenyl-9,10-dihydro-9,10-
ethenoanthracene}] (2a). To a solution of [Pd{k2-N2′,C1-2-(2′-
NH2C6H4)C6H4}(-Cl)]2 (0.25 g, 0.405 mmol) in acetone (8‒10 
mL) was added a solution of 1a (0.385 g, 0.81 mmol) in 
 dichloromethane (5‒7 mL). After stirring for 2 h, the solvent was 
removed under reduced pressure and the resulting brown oily 
residue purified by column chromatography, using 
CH2Cl2/methanol (97/3) as eluant, to give 2a as a pale yellow 
spectroscopically pure solid in 81% yield (0.52 g). An analytically 
pure sample that was also suitable for X-ray structure 
determination was grown by slow diffusion of a dichloromethane 
solution layered with hexane at room temperature. Mp: 188 °C 
(dec). 31P{1H} NMR (202.46 MHz, CDCl3, ): 49.5; 
1H NMR 
(500.16 MHz, CDCl3, δ): 7.82 (br, 1H, Ar-H), 7.46 (br, 1H, Ar-
H), 7.34 (br, 1H, Ar-H), 7.32‒7.14 (m, 11H, Ar-H), 7.02 (br, 4H, 
Ar-H), 6.96 (t, J = 7.3 Hz, 1H, Ar-H), 6.58 (t, J = 7.3 Hz, 1H, Ar-
H), 6.15 (t, J = 7.3 Hz, 1H, Ar-H), 6.10 (t, J = 5.5 Hz, 1H, 
bridgehead CH), 5.22 (t, J = 2.3 Hz, 1H, bridgehead CH), 4.86 
(br, 1H, N-H), 4.53 (br, 1H, N-H), 2.84 (br, 1H, Cy-H), 2.21 (br, 
1H, Cy-H), 1.64 (br, 3H, Cy-H), 1.43‒1.14 (br, 5H, Cy-H), 1.03‒
0.87 (br, 8H, Cy-H), 0.74 (br, 2H, Cy-H), 0.23 (br, 1H, Cy-H), 
0.09 (br, 1H, Cy-H); 13C{1H} NMR (125.76 MHz, CDCl3, δ): 
159.4 (C=CP), 148.2 (C6H4Q), 145.0 (C6H4Q), 144.7 (C6H4Q), 
144.4 (C6H4Q), 143.8 (C6H4Q), 140.4 (d, J = 2.0, C6H4Q), 140.1 
(C6H4Q), 139.3 (C6H4Q), 135.9 (d, J = 8.6 Hz, Ar), 135.2 (d, J = 
2.1 Hz, C6H5Q), 134.9 (d, J = 29.6 Hz, C=CP), 128.7 (ArCH), 
128.1 (ArCH), 127.7 (ArCH), 127.6 (ArCH), 126.9 (ArCH), 
126.8 (ArCH), 126.3 (ArCH), 125.2 (ArCH), 125.1 (ArCH), 
125.0 (br, ArCH), 124.7 (br, ArCH), 123.8 (br, ArCH), 122.9 (br, 
ArCH), 122.6 (br, ArCH), 120.5 (ArCH), 62.4 (d, J = 5.3 Hz, 
bridgehead CH), 56.6 (d, J = 12.2 Hz, bridgehead CH), 37.4 (d, J 
= 21.9 Hz, Cy-CH), 36.2 (d, J = 25.3 Hz, Cy-CH), 32.4 (Cy-CH2), 
30.8 (Cy-CH2), 30.2 (Cy-CH2), 29.8 (Cy-CH2), 28.0 (Cy-CH2), 
27.6 (Cy-CH2), 27.5 (Cy-CH2), 27.3 (Cy-CH2), 26.3 (Cy-CH2), 
25.9 (Cy-CH2); Anal. Calcd for C46H47ClNPPd: C, 70.23; H, 6.02; 
N, 1.78. Found: C, 70.67; H, 6.44; N, 1.91; LRMS (EI+) m/z 787.2 
[M]+.  
 
Synthesis of [Pd{2-N2′,C1-2-(2′-NH2C6H4)C6H4}Cl{11-
(diphenylphosphino)-12-phenyl-9,10-dihydro-9,10-
ethenoanthracene}] (2b). Compound 2b was prepared and 
purified according to the procedure described above for 2a and 
isolated as a spectroscopically pure light yellow solid in 75% 
yield. An analytically pure sample that was also suitable for X-ray 
structure determination was grown by slow diffusion of a 
dichloromethane solution layered with methanol at room 
temperature. Mp: 185 °C (dec). 31P{H} NMR (161.8 MHz, 
CH2Cl2, ):  30.9;
 1H NMR (400 MHz, CDCl3, ): 7.43–6.83 (m, 
29H, Ar-H), 6.25 (t, J = 6.7 Hz, 1H, Ar-H), 6.18 (t, J = 7.2 Hz, 
1H, Ar-H), 5.34 (d, J = 3.4 Hz, 1H, bridgehead H), 5.21 (d, J = 
7.6 Hz, 1H, bridgehead H), 4.77 (br s, 2H, NH2); 
13C {1H} NMR 
(100.5 MHz, CDCl3) δ = 162.3 (d, J = 7.7 Hz, CCP), 148.1 (C6H4 
Q), 144.8 (2 × C6H4 Q), 144.4 (2 × C6H4 Q), 139.9 (C6H4 Q), 
138.5 (C6H5 Q), 138.4 (C6H4 Q), 138.4 (C6H4 Q), 137.4 (C6H5), 
137.3 (C6H5), 135.3 (br, CP), 135.3 (C6H5), 135.2 (C6H5), 130.2 
(C6H5), 129.7 (br, C6H5 Q), 127.9 –127.6 (br m, 6 C, 2 × C6H5, 4 
× C6H4), 127.1 (C6H4), 127.1 (C6H4), 126.0 (C6H4), 125.4 (C6H4), 
125.1 (C6H4), 125.0 (C6H4), 125.0 (C6H4), 123.9 (br, 2 × C6H4), 
123.1 (2 × C6H4), 120.3 (C6H4), 60.9 (d, J = 7.7 Hz, bridgehead 
CH), 55.4 (d, J = 5.5 Hz, bridgehead CH), observed complexity 
due to the presence of rotamers. IR (neat, cm-1) 2981, 1488, 1459, 
1158, 1022, 968, 746, 694, 630; Anal. Calcd for C46H35ClNPPd: 
C, 71.32; H, 4.55; N, 1.81. Found: C, 71.78; H, 4.88; N, 2.07; 
HRMS (ESI+): exact mass calcd for C46H35NPClPd [M]
+ requires 
m/z 773.1230, found m/z 773.1208.  
 
Diethyl-2-bromophenylphosphonate (3). A flame-dried 
Schlenk flask was cooled to room temperature under vacuum, 
back-filled with nitrogen and charged with Pd(OAc)2 (0.210 g, 
0.934 mmol), PPh3 (2.45 g, 9.34 mmol), EtOH (180 mL), 1-
bromo-2-iodobenzene (6.0 mL, 46.7 mmol), diethylphosphite (30 
mL, 234 mmol), diisopropylethylamine (51.0 mL, 292 mmol) and 
the resulting mixture heated at refluxed for 48 h. After this time, 
the solution was allowed to cool to room temperature then diluted 
with Et2O and washed with 1 M HCl (200 mL).  The aqueous 
phase was extracted with Et2O (3 × 100 mL) and the organic 
fractions combined, washed with 2.5 M NaOH solution (50 mL), 
brine (50 mL) then dried over MgSO4, filtered and the solvent 
removed under reduced pressure. The crude product was purified 
by column chromatography eluting with hexane:acetone:Et3N 
(70:29:1) to give the product as a light yellow oil (8.90 g, 65%). 
31P{1H} NMR (161.8 MHz, CDCl3, ): 15.4; 
1H NMR (399.78 
MHz, CDCl3, δ): 8.02–7.96 (m, 1H, Ar-H), 7.66–7.62 (m, 1H, Ar-
H), 7.40–7.32 (m, 2H, Ar-H), 4.22–4.05 (m, 4H, OCH2CH3), 1.33 
(t, J = 7.1 Hz, 6H, OCH2CH3); 
13C{1H} NMR (100.5 MHz, 
CDCl3, δ): 136.4 (d, J = 8.4 Hz), 134.4 (d, J = 11.3 Hz), 133.7 (d, 
J = 2.6 Hz), 129.5 (d, J = 192 Hz), 127.0 (d, J = 13.6 Hz), 125.3 
(d, J = 3.8 Hz), 62.7 (d, J = 5.4 Hz), 16.4 (d, J = 6.6 Hz).  
 
Diethyl [2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)phenyl]phosphonate (5a). A flame-dried Schlenk flask was 
cooled to room temperature under vacuum, back-filled with 
nitrogen and charged with Pd(dppf)Cl2 (0.25 g, 0.023 mmol), 
KOAc (0.201 g, 2.05 mmol), bis(pinacolato)diboron (0.260 g, 
1.02 mmol), dioxane (4.0 mL), diethyl-2-
bromophenylphosphonate. (0.200 g, 0.68 mmol) and the resulting 
mixture heated at 90 oC for 84 h. After this time the solvent was 
removed and the crude product purified by column 
chromatography by using hexane/EtOAc (1:2) as eluent to give 
the 5a as a colourless oil in 63% yield (0.147 g). 31P{1H} NMR 
(161.8 MHz, CDCl3, δ): 20.5; 
11B NMR (128.3 MHz, CDCl3, δ): 
30.4; 1H NMR (399.78 MHz, CDCl3, δ): 7.82 (dd, J = 13.1, 7.2 
Hz, 1H, C6H4P), 7.62–7.58 (m, 1H, C6H4P), 7.49 (tt, J = 7.4, 1.6 
Hz, 1H, C6H4P), 7.44 (tdd, J = 7.4, 3.9, 1.3 Hz, 1H, C6H4P), 4.21–
4.02 (m, 4H, OCH2CH3), 1.40 (s, 12H, 4 × CH3), 1.32 (t, J = 7.1 
Hz, 6 H, OCH2CH3); 
13C{1H} NMR (100.5 MHz, CDCl3 δ): 
133.5 (d, J = 17.3 Hz, C6H4P), 132.3 (d, J = 11.0 Hz, C6H4P), 
131.7 (d, J = 187 Hz, C6H4P), 131.4 (d, J = 2.9 Hz, C6H4P), 129.2 
(d, J = 14.6 Hz, C6H4P), 84.4 (BOC Q), 62.1 (d, J = 5.1 Hz, 
OCH2CH3), 25.0 (4C, CH3), 16.5 (d, J = 6.6 Hz, OCH2CH3), CB 
not detected; IR (neat, cm-1) 1347, 1143, 1019, 962, 761, 564; 
Anal. Calcd for C16H26BO5P: C, 56.49; H, 7.70. Found: C, 56.81; 
H, 8.07; HRMS (ESI+): exact mass calcd for C16H26O5BP [M+H]
+ 
requires m/z 341.1689, found m/z 341.1678.  
 
Diethyl 1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
naphthalen-2-ylphosphonate (5b). A flame-dried Schlenk flask 
was cooled to room temperature under vacuum, back-filled with 
nitrogen and charged with diethyl 1-bromo-2-
naphthylphosphonate (1.50 g, 4.37 mmol), Pd(dppf)Cl2 (0.157 g, 
0.215 mmol), KOAc (1.30 g, 13.1 mmol), bis(pinacolato)diboron 
(1.67 g, 6.65 mmol) and dioxane (20 mL) and the resulting 
mixture heated to 90 oC for 16 h. The solvent was then removed 
and the crude product purified by column chromatography with 
hexane/EtOAc (1:2) as eluent to affords 5b as a white solid in 
59% yield (1.0 g). A spectroscopically and analytically pure 
crystalline sample was obtained by crystallization from hot n-
hexane. 31P{1H} NMR (161.8 MHz, CDCl3, δ): 21.4; 
11B NMR 
(128.3 MHz, CDCl3, δ): 30.1; 
1H NMR (399.78 MHz, CDCl3, δ): 
8.09–8.07 (m, 1H, C10H6), 7.86 (dd, J = 8.4, 4.0 Hz, 1H, C10H6), 
7.83–7.81 (m, 1H, C10H6), 7.72 (dd, J = 11.1, 8.4 Hz, 1H, C10H6), 
7.54–7.52 (m, 2H, C10H6), 4.23–4.00 (m, 4H, OCH2CH3), 1.54 (s, 
12H, 4 × CH3), 1.30 (t, J = 7.1 Hz, 6H, OCH2CH3); 
13C{1H} 
NMR (100.5 MHz, CDCl3, δ): 139.2 (br, C6H10 CB), 135.3 (d, J = 
19.9 Hz, C10H6 Q), 134.3 (d, J = 2.6 Hz, C10H6 Q), 129.4 (d, J = 
185 Hz, C10H6 CP), 129.0 (d, J = 14.1 Hz, C10H6), 128.6 (C10H6), 
128.4 (C10H6), 127.8 (C10H6), 126.7 (C10H6), 126.6 (d, J = 10.7 
Hz, C10H6), 84.7 (BOC Q), 62.1 (d, J = 4.6 Hz, OCH2CH3), 25.8 
 (4C, CH3), 16.4 (d, J = 6.4 Hz, OCH2CH3); Mp: 86-88 
oC; IR 
(neat, cm-1) 2978, 1288, 1124, 1019, 960, 940, 842, 749, 663, 539; 
Anal. Calcd for C20H28BO5P: C, 61.56; H, 7.23. Found: C, 61.78; 
H, 7.52; HRMS (ESI+): exact mass calcd for C20H29BO5P [M+H]
+ 
requires m/z 391.1846, found m/z 391.1842.  
 
General Procedure for the Palladium-Catalyzed Suzuki-
Miyaura Cross Coupling of Diethyl-(2-
bromophenyl)phosphonate with Aryl Boronic Acids. A flame-
dried Schlenk flask was cooled to room temperature under 
vacuum, back-filled with nitrogen and charged with catalyst (2.0 
µmol, 0.5 mol% or 0.4 mol, 0.1 mol%), K3PO4 (0.170 g, 0.80 
mmol), boronic acid (0.60 mmol) and THF (2.0 mL). Diethyl-(2-
bromophenyl)phosphonate (0.117, 0.40 mmol) and water (1.0 
mL) were then added and the resulting mixture  heated at 70 ºC 
for the allocated time. After this time, the reaction mixture was 
cooled to room temperature, diluted with diethyl ether (5 mL) and 
filtered through a silica plug by flushing with CH2Cl2/MeOH 
(9/1). The solvent was then removed under reduced pressure and 
the product purified by column chromatography with 
EtOAc/hexane (2/1) as eluent.  
 
General Procedure for the Palladium-Catalyzed Suzuki-
Miyaura Cross Coupling of Diethyl [2-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)phenyl]phosphonate (5a) with Aryl 
and Heteroaryl Bromides. A flame-dried Schlenk flask was 
cooled to room temperature under vacuum, back-filled with 
nitrogen and charged with catalyst (1 mol, 0.5 mol% or 4 mol, 
2.0 mol%), K3PO4 (0.085 g, 0.40 mmol), [2-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)phenyl]phosphonate (0.102 g, 0.30 
mmol) and THF (2.0 mL). Aryl halide (0.20 mmol) and H2O (1.0 
mL) were then added and the resulting mixture heated at 70 ºC for 
the allocated time. After this time, the reaction mixture was 
cooled to room temperature, diluted with diethyl ether (5 mL) and 
filtered through a silica plug by flushing with CH2Cl2/MeOH 
(9/1). The solvent was then removed under reduced pressure and 
the product purified by column chromatography with 
EtOAc/hexane (2/1) as eluent. 
 
General Procedure for the Palladium-Catalyzed Suzuki-
Miyaura Cross Coupling between Diethyl 1-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)-naphthalen-2-
ylphosphonate (5b) and Aryl/Heteroaryl Bromides. A flame-
dried Schlenk flask was cooled to room temperature under 
vacuum, back-filled with nitrogen and charged with catalyst (1 
mol, 0.5 mol% or 4 mol, 2.0 mol%), K3PO4 (0.085 g, 0.40 
mmol), aryl bromide (0.20 mmol) and diethyl 1-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)-naphthalen-2-ylphosphonate 
(0.978 g, 0.3 mmol). THF (2.0 mL), aryl bromide (2.0 mmol) and 
water (1.0 mL) were added and the resulting mixture heated at 70 
ºC for the allocated time. After this time, the reaction mixture was 
cooled to room temperature, diluted with diethyl ether (5 mL) and 
filtered through a silica plug by flushing with CH2Cl2/MeOH 
(9/1). The solvent was then removed under reduced pressure and 
the product purified by column chromatography with 
EtOAc/hexane (2/1) as eluent.  
 
Diethyl 1,1'-biphenyl-2-ylphosphonate (4a) (Table 1, 
entries 1-3 and Table 2, entries 1-3):  31P {H} NMR (161.8 
MHz, CDCl3, δ): 18.7; 
1H NMR (400 MHz, CDCl3, δ): 7.98 (ddd, 
J = 14.3, 7.7, 1.3 Hz, 1H, C6H4P), 7.46 (tt, 7.5, 1.4 Hz, 1H, 
C6H4P), 7.38–7.28 (m, 5H, C6H5, C6H4P), 7.24 (ddd, J = 7.2, 5.6, 
1.1 Hz, 1H, C6H5), 3.90–3.71 (m, 4H, OCH2CH3), 1.05 (t, J = 7.1 
Hz, 6H, OCH2CH3); 
13C{1H} NMR (100.5 MHz, CDCl3, δ): 
145.8 (d, J = 9.8 Hz, C6H4P Q), 141.2 (d, J = 4.3 Hz, C6H5 Q) , 
133.6 (d, J = 9.7 Hz, C6H4P), 131.8 (d, J = 2.7 Hz, C6H4P), 131.2 
(d, J = 14.0 Hz, C6H4P), 129.1 (2C, C6H5 m-C), 127.3 (2C, C6H5 
σ-C), 126.7 (C6H5 ρ-C), 126.7 (d, J = 14.0 Hz, C6H4P), 126.7 (d, J 
= 187 Hz, C6H4P CP), 61.6 (d, J = 6.1 Hz, OCH2CH3), 15.9 (d, J 
= 6.8 Hz, OCH2CH3); IR (neat, cm
-1) 1239, 1018, 958, 754, 700; 
HRMS (ESI+): exact mass calcd for C16H20PO3 [M+H]
+ requires 
m/z 291.1150, found m/z 291.1139.   
 
1-(2-Diethoxyphosphorylphenyl)-4-methoxy-benzene (4b) 
(Table 1, entries 4-6 and Table 2 entries 4-6): 31P{1H} NMR 
(161.8 MHz, CDCl3, δ): 19.0; 
1H NMR (400 MHz, CDCl3, δ): 
7.98 (dd, J = 14.1, 7.8 Hz, 1H, C6H4P), 7.48 (t, 7.5 Hz, 1H, 
C6H4P), 7.38–7.33 (m, 3H, 2 × C6H4OCH3 + C6H4P), 7.27–7.24 
(m, 1H, C6H4P), 6.89 (d, J = 8.7 Hz, 2H, C6H4OCH3), 3.9–3.75 
(m, 4H, OCH2CH3), 3.78 (s, 3H OCH3), 1.11 (t, J = 7.1 Hz, 6H, 
OCH2CH3); 
13C{1H} NMR (100.5 MHz, CDCl3, δ): 159.0 
(C6H4OCH3 Q), 145.7 (d, J = 10.0 Hz, C6H4P Q), 133.7 (d, J = 
9.4 Hz, C6H4P), 133.7 (C6H4OCH3 Q), 131.9 (d, J = 2.7 Hz, 
C6H4P), 131.5 (d, J = 14.2 Hz, C6H4P), 130.4 (2C, C6H4OCH3), 
126.8 (d, J = 187 Hz, C6H4P CP), 126.5 (d, J = 14.2 Hz, C6H4P), 
112.8 (2 × C6H4OCH3), 61.7 (d, J = 6.0 Hz, OCH2CH3), 55.2 
(OCH3), 16.1 (d, J = 6.8 Hz, OCH2CH3); Mp: 63–64
oC; IR (neat, 
cm-1) 1241, 1021, 956, 763, 552; Anal. Calcd for C17H21O4P: C, 
63.74; H, 6.61. Found: C, 64.11; H, 6.79; HRMS (ESI+): exact 
mass calcd for C17H21O4P [M+H]
+ requires m/z 321.1256, found 
m/z 321.1265.    
 
1-(2-Diethoxyphosphorylphenyl)-4-chloro-benzene (4c) 
(Table 1, entries 7-9 and Table 2, entries 7-9): 31P{1H} NMR 
(161.8 MHz, CDCl3, δ): 18.4; 
1H NMR (400 MHz, CDCl3, δ): 
7.97 (ddd, J = 14.5, 7.6, 1.2 Hz, 1H, C6H4P), 7.49 (tt, J = 7.4, 1.3 
Hz, 1H, C6H4P), 7.38 (tdd, J = 7.5, 3.5, 1.1 Hz, 1H, C6H4P), 7.30 
(s, 4H, C6H4Cl), 7.23–7.20 (m, 1H, C6H4P), 3.94–3.77 (m, 4H, 
OCH2CH3), 1.09 (t, J = 7.1 Hz, 6H, OCH2CH3); 
13C{1H} NMR 
(100.5 MHz, CDCl3, δ): 144.9 (d, J = 9.6 Hz, C6H4P Q), 140.0 (d, 
J = 4.0 Hz, C6H4Cl Q), 134.0 (d, J = 9.6 Hz, C6H4P), 133.8 
(C6H4Cl Q), 132.3 (d, J = 2.7 Hz, C6H4P), 131.4 (d, J = 13.9 Hz, 
C6H4P), 130.8 (2C, C6H4Cl), 127.8 (2C, C6H4Cl), 127.4 (d, J = 
14.7 Hz, C6H4P), 127.1 (d, J = 188 Hz, C6H4P CP), 62.1 (d, J = 
5.9 Hz, OCH2CH3), 16.2 (d, J = 6.7 Hz, OPCH2CH3); IR (neat, 
cm-1) 1232, 1017, 959, 764, 569; Anal. Calcd for C16H18ClO3P: C, 
59.18; H, 5.59. Found: C, 59.84; H, 5.96; HRMS (ESI+): exact 
mass calcd for C16H19PO3Cl [M+H]
+ requires m/z 325.0760, 
found m/z 325.0748.  
 
1-(2-Diethoxyphosphorylphenyl)-2-methoxy-benzene (4d) 
(Table 1, entries 10-12 and Table 2, entries 10-12): 31P{1H} 
NMR (161.8 MHz, CDCl3, δ): 18.7; 
1H NMR (400 MHz, CDCl3, 
δ): 8.03 (ddd, J = 14.2, 7.7, 1.3 Hz, 1H, C6H4P), 7.50 (tt, 7.5, 1.5 
Hz, 1H, C6H4P), 7.39 (tdd, J = 7.5, 3.6, 1.2 Hz, 1H, C6H4P), 7.32 
(td, J = 8.1, 1.7 Hz, 1H, C6H4OCH3), 7.28–7.24 (m, 1H, C6H4P), 
7.21 (dd, J = 7.4, 1.7 Hz, 1H, C6H4OCH3), 6.95 (dt, J = 7.4, 0.8 
Hz, 1H, C6H4OCH3), 6.91 (d, J = 8.3 Hz, 1H, C6H4OCH3), 3.93–
3.75 (m, 4H, OCH2CH3), 3.69 (s, 3 H, OCH3), 1.12 (t, J = 7.0 Hz, 
3 H, OCH2CH3), 1.11 (t, J = 7.0 Hz, 3H, PCH2CH3); 
13C{1H} 
NMR (100.5 MHz, CDCl3, δ): 156.6 (C6H4OCH3 Q), 142.3 (d, J 
= 9.4 Hz, C6H4P Q), 133.7 (d, J = 10.0 Hz, C6H4P) , 131.8 (d, J = 
14.1 Hz, C6H4P), 131.5 (d, J = 2.5 Hz, C6H4P), 131.4 
(C6H4OCH3), 129.9 (d, J = 3.9 Hz, C6H4OCH3 Q), 129.0 
(C6H4OCH3), 127.6 (d, J = 187 Hz, C6H4P CP), 126.8 (d, J = 14.9 
Hz, C6H4P), 119.5 (C6H4OCH3), 110.2 (C6H4OCH3),  61.6 (t, J = 
6.1 Hz, OCH2CH3), 55.3 (OCH3), 16.1 (t, J = 6.7 Hz, OCH2CH3); 
IR (neat, cm-1) 1230, 1019, 959, 748, 554; Anal. Calcd for 
C17H21O4P: C, 63.74; H, 6.61. Found: C, 64.24; H, 6.92; HRMS 
(ESI+): exact mass calcd for C17H21O4P [M+H]
+ requires m/z 
321.1256, found m/z 321.1270. 
 
1-(2-Diethoxyphosphorylphenyl)-2-methyl-benzene (4e) 
(Table 1, entries 13-15 and Table 2 entries 13-15): 31P{1H} 
 NMR (161.8 MHz, CDCl3, δ):  18.3; 
1H NMR (400 MHz, CDCl3, 
δ): 8.04 (ddd, J = 14.2, 7.8, 1.3 Hz, 1H, C6H4P), 7.54 (tt, J = 7.6, 
1.4 Hz, 1H, C6H4P), 7.43 (tdd, J = 7.5, 3.7, 1.2 Hz, 1H, C6H4P), 
7.25–7.17 (m, 5H, C6H4CH3 + C6H4P), 3.95–3.69 (m, 4H, 
OCH2CH3), 2.05 (s, 3H, CH3), 1.16 (t, J = 7.1 Hz, 3H, 
OCH2CH3), 1.12 (t, J = 7.1 Hz, 3 H, OCH2CH3); 
13C{1H} NMR 
(100.5 MHz, CDCl3, δ): 145.4 (d, J = 9.8 Hz, C6H4P Q), 140.7 (d, 
J = 3.9 Hz, C6H4CH3 Q), 136.3 (C6H4CH3 Q), 133.6 (d, J = 10.3 
Hz, C6H4P), 131.9 (d, J = 2.7 Hz, C6H4P), 131.1 (d, J = 14.4 Hz, 
C6H4P), 130.0 (C6H4CH3), 129.5 (C6H4CH3), 127.7 (C6H4CH3), 
127.6 (d, J = 190 Hz, C6H4P CP), 126.9 (d, J = 14.9 Hz, C6H4P), 
124.6 (C6H4CH3), 61.8 (t, J = 6.2 Hz, OCH2CH3), 20.4 (CH3), 
16.3 (d, J = 6.6 Hz, OCH2CH3), 16.2 (d, J = 6.7 Hz, OCH2CH3); 
IR (neat, cm-1) 1240, 1017, 958, 766, 552; HRMS (ESI+): exact 
mass calcd for C17H21O3P [M+H]
+ requires m/z 305.1307, found 
m/z 305.1304.  
    
 2-Methoxy-1-(2ʹ -diethoxyphosphorylphenyl)naphthylene 
(4f) (Table 1, entries 16-18 and Table 2, entries 16-18): 
31P{1H}  NMR (161.8 MHz, CDCl3, δ): 18.3; 
1H NMR (400 
MHz, CDCl3, δ): 8.19 (dd, J = 14.2, 7.7 Hz, 1H, C6H4P), 7.88 (d, 
J = 9.1 Hz, 1H, C10H6OCH3), 7.79–7.77 (m, 1H, C10H6OCH3), 
7.63 (tt, J = 7.4, 1.3 Hz, 1H, C6H4P), 7.54–7.49 (m, 1H, C6H4P), 
7.34 (d, J = 9.1 Hz, 1H, C10H6OCH3), 7.30–7.24 (m, 3 H, 
C10H6OCH3 + C6H4P), 7.12–7.10 (m, 1H, C10H6OCH3), 3.83 (s, 
3H, OCH3),  3.80–3.49 (m, 4H, OCH2CH3), 0.96 (t, J = 7.1 Hz, 
3H,  OCH2CH3), 0.71 (t, J = 7.1 Hz, 3H, OCH2CH3); 
13C{1H} 
NMR (100.5 MHz, CDCl3, δ): 154.1 (C10H6OCH3 Q), 140.6 (d, J 
= 8.9 Hz, C6H4P Q), 134.3 (d, J = 10.0 Hz, C6H4P), 134.1 
(C10H6OCH3 Q), 132.2 (C6H4P), 132.2 (d, J = 11.2 Hz, C6H4P), 
129.5 (C10H6OCH3), 129.3 (d, J = 189 Hz, C6H4P CP), 128.4 
(C10H6OCH3 Q), 127.6 (C10H6OCH3), 127.1 (d, J = 14.7 Hz, 
C6H4P), 125.9 (C10H6OCH3), 125.6 (C10H6OCH3), 123.7 (d, J = 
3.8 Hz, C10H6OCH3 Q), 123.2 (C10H6OCH3), 112.9 (C10H6OCH3), 
61.6 (d, J = 5.7 Hz, OCH2CH3), 61.4 (d, J = 6.0 Hz, OCH2CH3), 
56.2 (OCH3), 16.0 (d, J = 6.6 Hz, OCH2CH3), 15.5 (d, J = 7.0 Hz, 
PCH2CH3); Mp: 128–129 
oC; IR (neat, cm-1) 1234, 1020, 966, 
771, 750, 559; Anal. Calcd for C21H23O4P: C, 68.10; H, 6.26. 
Found: C, 68.41; H, 6.56; HRMS (ESI+): exact mass calcd for 
C21H23PO4 [M+Na]
+ requires m/z 393.1232, found m/z 393.1234.  
 
Methyl (2ʹ-diethoxyphosphorylphenyl [1,1ʹ-biphenyl])-2-
benzoate (4g) (Table 2, entries 19-21): 31P{1H} NMR (161.8 
MHz, CDCl3, δ):  18.8; 
1H NMR (400 MHz, CDCl3, δ): 8.04 (dd, 
J = 7.8, 1.4 Hz, 1H, C6H4CO2CH3), 8.01 (ddd, J = 14.3, 7.7, 1.3 
Hz, 1H, C6H4P), 7.56–7.52 (m, 1H, C6H4P), 7.50 (dd, J = 7.5, 1.4 
Hz, 1H, C6H4CO2CH3), 7.45 (dd, J = 7.7, 1.3 Hz, 1H, 
C6H4CO2CH3), 7.45–7.41 (m, 1H, C6H4P), 7.30 (dd, J = 7.6 Hz, 
1.3 Hz, 1H, C6H4CO2CH3), 7.23–7.20 (m, 1H, C6H4P), 3.94–3.71 
(m, 4H, OCH2CH3), 3.57 (s, 3H, OCH3), 1.10 (q, J = 6.9 Hz, 6H, 
OCH2CH3); 
13C{1H} NMR (100.5 MHz, CDCl3, δ): 167.2 (CO), 
145.7 (d, J = 8.9 Hz, C6H4P Q), 142.4 (d, J = 4.0 Hz, 
C6H4CO2CH3 Q), 133.3 (d, J = 9.9 Hz, C6H4P), 131.6 (d, J = 2.7 
Hz, C6H4P), 131.5 (C6H4CO2CH3), 131.0 (C6H4CO2CH3), 130.2 
(d, J = 14.2 Hz, C6H4P), 130.0 (C6H4CO2CH3), 130.0 
(C6H4CO2CH3 Q), 127.8 (C6H4CO2CH3), 126.8 (d, J =14.9 Hz, 
C6H4P), 126.3 (d, J = 187 Hz, C6H4P CP), 61.9 (d, J = 6.1 Hz, 
OCH2CH3), 61.6 (d, J = 5.8 Hz, OCH2CH3), 51.8 (OCH3), 16.2–
16.1 (m, OCH2CH3); IR (neat, cm
-1) 1721, 1239, 1025, 957, 777, 
765, 551; Anal. Calcd for C18H21O4P: C, 65.05; H, 6.37. Found: 
C, 65.19; H, 6.59; HRMS (ESI+): exact mass calcd for C18H22O5P 
[M+H]+ requires m/z 349.1205, found m/z 349.1217.  
 
Diethyl (2-(pyridin-2-yl)phenyl)phosphonate (4h) (Table 2, 
entries 22-24): 31P{1H} NMR (161.8 MHz, CDCl3, δ): 18.4; 
1H 
NMR (400 MHz, CDCl3, δ): 8.62 (d, J = 4.9 Hz, 1H, C5H4N), 
7.98 (dd, J = 14.2, 7.7 Hz, 1H, C6H4P), 7.69 (t, 7.6 Hz, 1H, 
C5H4N), 7.60 (d, J = 8.2 Hz, 1H, C5H4N), 7.56 (d, J = 7.5 Hz, 1H, 
C6H4P), 7.49–7.44 (m, 2H, C6H4P), 7.26–7.23 (m, 1H, C5H4N), 
3.96–3.83 (m, 4H, OCH2CH3), 1.10 (t, J = 7.0 Hz, 6H, 
OCH2CH3); 
13C{1H} NMR (100.5 MHz, CDCl3, δ): 158.9 (d, J = 
4.5 Hz, C5H4N Q), 148.8 (C5H4N), 144.7 (d, J = 9.9 Hz, C6H4P 
Q), 135.6 (C5H4N), 133.8 (d, J = 9.3 Hz, C6H4P), 132.2 (d, J = 2.5 
Hz, C6H4P), 130.9 (d, J = 13.6 Hz, C6H4P), 127.9 (d, J = 14.3 Hz, 
C6H4P), 126.5 (d, J = 186 Hz, C6H4P CP), 124.7 (C6H4N), 122.4 
(C6H4N), 62.0 (t, J = 5.8 Hz, OCH2CH3), 16.1 (d, J = 7.0 Hz, 
OCH2CH3); Mp: 74–76
oC; IR (neat, cm-1) 1259, 1083, 1011, 794, 
753; Anal. Calcd for C15H18NO3P: C, 61.85; H, 6.23; N, 4.81. 
Found: C, 62.17; H, 6.43; N, 5.18; HRMS (ESI+): exact mass 
calcd for C15H18O3NP [M+H]
+ requires m/z 292.1103, found m/z 
292.1097. 
 
Diethyl (2-(pyrimid-2-yl)phenyl)phosphonate (4i) (Table 2, 
entries 25-27): 31P{1H} NMR (161.8 MHz, CDCl3, δ): 18.0; 
1H 
NMR (400 MHz, CDCl3, δ): 8.82 (d, J = 5.0 Hz, 2H, C4H3N2), 
7.99 (dd, J = 14.3, 7.3 Hz, 1H, C6H4P), 7.75–7.72 (m, 1H, 
C6H4P), 7.62 (t, J = 7.6 Hz, 1H, C6H4P), 7.53 (tdd, J = 7.7, 3.6, 
1.2 Hz, 1H, C6H4P), 7.28 (t, J = 4.8 Hz, 1H, C4H3N2), 4.11–3.95 
(m, 4 H, OCH2CH3), 1.22 (t, J = 7.1 Hz, 6H, OCH2CH3); 
13C{1H} 
NMR (100.5 MHz, CDCl3, δ): 167.1 (d, J = 4.8 Hz, C4H3N2 Q), 
156.7 (2C, C4H3N2), 143.5 (d, J = 9.4 Hz, C6H4P Q), 133.9 (d, J = 
8.5 Hz, C6H4P), 132.2 (d, J = 2.7 Hz, C6H4P), 130.6 (d, J = 13.1 
Hz, C6H4P), 128.9 (d, J = 14.0 Hz, C6H4P), 127.3 (d, J = 187 Hz, 
C6H4P CP), 119.5 (C4H3N2), 62.2 (d, J = 5.7 Hz, OCH2CH3), 16.3 
(t, J = 6.7 Hz, OCH2CH3); IR (neat, cm
-1) 1557, 1413, 1233, 
1018, 958, 759, 566; Anal. Calcd for C14H17N2O3P: C, 57.53; H, 
5.86; N, 9.58. Found: C, 57.98; H, 6.22; N, 9.89; HRMS (ESI+): 
exact mass calcd for C14H18O3N2P [M+H]
+ requires m/z 293.1055, 
found m/z 293.1066.      
 
 Diethyl (2-(pyrimid-5-yl)phenyl)phosphonate (4j) (Table 
2, entries 28-30):. 31P{1H} NMR (161.8 MHz, CDCl3, δ): 17.6; 
1H NMR (400 MHz, CDCl3, δ): 9.22 (s, 1H, C4H3N2), 8.76 (s, 2H, 
C4H3N2), 8.11 (dd, J = 14.5, 7.6 Hz, 1H, C6H4P), 7.64 (t, 7.6 Hz, 
1H, C6H4P), 7.55 (td, J = 7.7, 3.6 Hz, 1H, C6H4P), 7.32–7.29 (m, 
1H, C6H4P), 4.00–3.89 (m, 4H, OCH2CH3), 1.16 (t, J = 7.1 Hz, 
6H, OCH2CH3); 
13C{1H} NMR (100.5 MHz, CDCl3, δ): 157.7 
(C4H3N2), 156.5 (2 x C4H3N2), 138.3 (d, J = 8.7 Hz, C6H4P Q), 
135.2 (d, J = 4.1 Hz, C4H3N2 Q), 134.3 (d, J = 9.6 Hz, C6H4P), 
132.6 (d, J = 2.5 Hz, C6H4P), 131.3 (d, J = 13.5 Hz, C6H4P), 
128.7 (d, J = 14.5 Hz, C6H4P), 128.1 (d, J = 187.2 Hz, C6H4P CP), 
62.3 (d, J = 6.1 Hz, OCH2CH3), 16.3 (d, J = 6.4 Hz, OCH2CH3); 
IR (neat, cm-1) 1408, 1238, 1015, 963, 573; Anal. Calcd for 
C14H17N2O3P: C, 57.53; H, 5.86; N, 9.58. Found: C, 57.78; H, 
6.06; N, 10.03; HRMS (ESI+): exact mass calcd for C14H18O3N2P 
[M+H]+ requires m/z 293.1055, found m/z 293.1068.  
 
1-(2-Diethoxyphosphorylphenyl)-4-acetophenone (4k) 
(Table 2, entries 31-32): 31P{1H} NMR (161.8 MHz, CDCl3, δ): 
18.2; 1H NMR (400 MHz, CDCl3, δ): 8.02 (ddd, J = 15.1, 8.1, 1.3 
Hz, 1H, C6H4P), 7.97 (d, J = 8.3 Hz, 2H, C6H4COCH3), 7.56 (tt, J 
= 7.6, 1.2 Hz, 1H, C6H4P), 7.52 (d, J = 8.3 Hz, 2H, C6H4COCH3), 
7.45 (tdd, J = 7.6, 3.5, 1.2 Hz, 1H, C6H4P), 7.30–7.27 (m, 1H, 
C6H4P), 3.97–3.80 (m, 4H, OCH2CH3), 2.62 (s, 3H, CH3), 1.11 (t, 
J = 7.1 Hz, 6H, OCH2CH3); 
13C{1H} NMR (100.5 MHz, CDCl3, 
δ): 198.0 (CO), 146.4 (d, J = 4.1 Hz, C6H4COCH3 Q), 144.8 (d, J 
= 9.6 Hz, C6H4P Q), 136.1 (C6H4COCH3 Q), 133.9 (d, J = 9.4 Hz, 
C6H4P), 132.2 (d, J = 2.6 Hz, C6H4P), 131.0 (d, J = 14.0 Hz, 
C6H4P), 129.7 (2 × C6H4COCH3), 127.6 (2C, C6H4COCH3), 127.6 
(d, J = 14.6 Hz, C6H4P), 126.9 (d, J = 187 Hz, C6H4P CP), 62.0 (t, 
J = 6.0 Hz, OCH2CH3), 26.8 (CH3), 16.2 (d, J = 6.6 Hz, 
OCH2CH3); Mp: 78–79 
oC; IR (neat, cm-1) 1680, 1230, 1046, 
1019, 960, 767, 569; Anal. Calcd for C18H21O4P: C, 65.05; H, 
6.37. Found: C, 65.44; H, 6.63; HRMS (ESI+) exact mass 
 calculated for C18H22O4P [M+H]
+ requires m/z = 333.1256, found 
m/z = 333.1268.  
 
Diethyl (1-(4'-methoxyphenyl)-2-naphthyl)phosphonate 
(4l) (Table 3, entries 1-2): 31P{1H} NMR (161.8 MHz, CDCl3, 
δ): 19.0; 1H NMR (400 MHz, CDCl3, δ): 8.07 (dd, J = 12.1, 8.6 
Hz, 1H, C10H6P), 7.93–7.90 (m, 1H, C10H6P), 7.88 (d, J = 8.5 Hz, 
1H, C10H6P), 7.54 (t, J = 7.4 Hz, 1H, C10H6P), 7.50 (d, J = 8.5 Hz, 
1H, C10H6P), 7.41–7.37 (m, 1H, C10H6P), 7.29 (d, J = 8.6 Hz, 2H, 
C6H4OCH3), 7.01 (d, J = 8.6 Hz, 2 H, C6H4OCH3), 4.00–3.82 (m, 
4H, OCH2CH3), 3.90 (s, 3H, OCH3), 1.20 (t, J = 7.1 Hz, 6H, 
OCH2CH3); 
13C{1H} NMR (100.5 MHz, CDCl3, δ): 159.3 
(C6H4OCH3 Q), 145.4 (d, J = 10.4 Hz, C10H6P Q), 135.2 (d, J = 
2.5 Hz, C10H6P Q), 133.5 (d, J = 16.1 Hz, C10H6P Q), 131.8 (2 × 
C6H4OCH3), 130.5 (d, J = 5.7 Hz, C6H4OCH3 Q), 128.4 (d, J = 
10.1 Hz, C10H6P), 127.9 (C10H6P), 127.8 (C10H6P), 127.8 
(C10H6P), 127.3 (d, J = 14.4 Hz, C10H6P), 126.6 (C10H6P), 125.1 
(d, J = 188 Hz, C10H6P CP), 113.0 (2C, C6H4OCH3), 61.8 (d, J = 
6.0 Hz, OCH2CH3), 55.4 (OCH3), 16.3 (d, J = 6.7 Hz, OCH2CH3); 
Mp: 105oC; IR (neat, cm-1) = 1237, 1021, 972, 956; Anal. Calcd 
for C21H23O4P: C, 68.10; H, 6.26. Found: C, 68.43; H, 6.54; 
HRMS (ESI+): exact mass calcd for C21H24O4P [M+H]
+ requires 
m/z 371.1412, found m/z 371.1397.       
 
Diethyl (1-(4'-chlorophenyl)-2-naphthyl)phosphonate (4m) 
(Table 3, entries 3-4): 31P{1H} NMR (161.8 MHz, CDCl3, δ): 
18.6; 1H NMR (400 MHz, CDCl3, δ): 8.07 (dd, J = 12.1, 8.6 Hz, 
1H, C10H6P), 7.95 (dd, J = 8.6, 3.7 Hz, 1H, C10H6P), 7.90 (d, J = 
8.2 Hz, 1H, C10H6P), 7.57 (ddd, J = 8.1, 5.0, 2.9 Hz, 1H, C10H6P), 
7.46 (d, J = 8.3 Hz, 2H, C6H4Cl), 7.42–7.41 (m, 2H, C10H6P), 
7.31 (d, J = 8.3 Hz, 2H, C6H4Cl), 4.02–3.84 (m, 4H, OCH2CH3), 
1.20 (t, J = 7.1 Hz, 6H, OCH2CH3); 
13C{1H} NMR (100.5 MHz, 
CDCl3, δ): 144.0 (d, J = 9.9 Hz, C10H6P Q), 136.9 (d, J = 5.2 Hz, 
C6H4Cl Q), 135.1 (d, J = 2.4 Hz, C10H6P Q), 133.9 (C6H4Cl Q), 
132.9 (d, J = 15.7 Hz, C10H6P Q), 132.1 (2C, C6H4Cl), 128.3 (d, J 
= 9.7 Hz, C10H6P), 128.1 (C10H6P), 128.0 (C10H6P), 127.8 (d, J = 
14.0 Hz, C10H6P), 127.8 (2C, C6H4Cl), 127.5 (C10H6P), 126.9 
(C10H6P), 125.1 (d, J = 188 Hz, C10H6P CP), 62.0 (d, J = 5.9 Hz, 
OCH2CH3), 16.3 (d, J = 6.7 Hz, OCH2CH3); Mp: 60–61
oC; IR 
(neat, cm-1) = 1241, 1049, 1016, 955, 818, 749, 666, 566; Anal. 
Calcd for C20H20ClO3P: C, 64.09; H, 5.28. Found: C, 64.61; H, 
5.65; HRMS (ESI+): exact mass calcd for C20H20NaO3P [M+Na]
+ 
requires m/z 397.0736, found m/z 397.0732.  
 
Diethyl (1-(2ʹ-methylphenyl)-2-naphthyl)phosphonate (4n) 
(Table 3, entries 5-6): 31P{1H} NMR (161.8 MHz, CDCl3, δ): 
18.6; 1H NMR (400 MHz, CDCl3, δ): 8.09 (dd, J = 12.1, 8.6 Hz, 
1H, C10H6P), 7.94–7.92 (m, 1H, C10H6P), 7.90 (d, J = 8.6 Hz, 1H, 
C10H6P), 7.55 (t, J = 7.44 Hz, 1H, C10H6P), 7.39–7.28 (m, 5H, 
C10H6P + C6H4CH3), 7.21 (d, J = 6.8 Hz, 1H, C6H4CH3), 3.99–
3.73 (m, 4H, OCH2CH3), 1.92 (s, 3H, CH3), 1.19 (t, J = 7.1 Hz, 
3H, OCH2CH3), 1.17 (t, J = 7.1 Hz, 3H, OCH2CH3); 
13C{1H} 
NMR (100.5 MHz, CDCl3, δ): 145.0 (d, J = 10.0 Hz, C10H6P Q), 
137.9 (d, J = 5.2 Hz, C6H4CH3 Q), 137.7 (C6H4CH3 Q), 135.1 (d, 
J = 2.5 Hz, C10H6P Q), 132.5 (d, J = 16.3 Hz, C10H6P Q), 130.8 
(C6H4CH3), 129.4 (2C, C6H4CH3), 128.4 (d, J = 10.3 Hz, C10H6P), 
128.1 (C10H6P), 127.9 (C10H6P), 127.4 (d, J = 14.5 Hz, C10H6P), 
127.2 (C10H6P), 126.9 (C10H6P), 125.0 (C6H4CH3), 125.0 (d, J = 
190 Hz, C10H6P CP), 62.0 (d, J = 6.5 Hz, OCH2CH3), 61.9 (d, J = 
6.0 Hz, OCH2CH3), 20.1 (CH3), 16.4 (d, J = 6.6 Hz, OCH2CH3), 
16.2 (d, J = 6.8 Hz, OCH2CH3); IR (neat, cm
-1) = 1241, 1049, 
1020, 955, 753, 649, 570, 533; Anal. Calcd for C21H23O3P: C, 
71.17; H, 6.54. Found: C, 71.59; H, 6.87; HRMS (ESI+): exact 
mass calcd for C21H24O3P [M+H]
+ requires m/z 355.1463, found 
m/z 343.1452.  
 
Diethyl (1-(2'-methoxyphenyl)-2-naphthyl)phosphonate 
(4o) (Table 3, entry 7-8): 31P{1H} NMR (161.8 MHz, CDCl3, δ): 
19.0; 1H NMR (400 MHz, CDCl3, δ): 8.11 (dd, J = 12.0, 8.6 Hz, 
1H, C10H6P), 7.92 (dd, J = 8.6, 3.7 Hz, 1H, C10H6P), 7.88 (d, J = 
8.2 Hz, 1H, C10H6P), 7.53 (ddd, J = 8.1, 6.0, 1.9 Hz, 1H, C10H6P), 
7.47–7.43 (m, 1H, C6H4OCH3), 7.41–7.35 (m, 2H, C10H6P), 7.23 
(dd, J = 7.4, 1.7 Hz, 1H, C6H4OCH3), 7.07 (td, J = 7.5, 1.0 Hz, 
1H, C6H4OCH3), 7.01 (d, J = 8.3 Hz, 1H, C6H4OCH3), 4.00–3.78 
(m, 4H, OCH2CH3), 3.64 (s, 3H, OCH3), 1.17 (t, J = 7.0 Hz, 3H, 
OCH2CH3), 1.16 (t, J = 7.0 Hz, 3H, OCH2CH3); 
13C{1H} NMR 
(100.5 MHz, CDCl3, δ): 157.6 (C6H4OCH3 Q), 142.6 (d, J = 9.6 
Hz, C10H6P Q), 135.0 (d, J = 2.2 Hz, C10H6P Q), 132.9 (d, J = 
15.9 Hz, C10H6P Q), 132.3 (C6H4OCH3), 129.6 (C6H4OCH3), 
128.7 (d, J = 10.2 Hz, C10H6P), 128.0 (C10H6P), 127.8 (C10H6P), 
127.4 (d, J = 14.4 Hz, C10H6P), 127.4 (C10H6P), 127.2 (d, J = 5.2 
Hz, C6H4OCH3 Q), 126.5 (C10H6P), 125.1 (d, J = 188 Hz, C10H6P 
CP), 120.0 (C6H4OCH3), 110.2 (C6H4OCH3), 61.9 (d, J = 5.5 Hz, 
OCH2CH3), 61.7 (d, J = 5.9 Hz, OCH2CH3), 55.4 (OCH3), 16.3 
(d, J = 6.7 Hz, OCH2CH3), 16.2 (d, J = 6.7 Hz, OCH2CH3); Mp: 
60–61oC; IR (neat, cm-1) 1226, 1212, 1047, 1021, 974, 754, 648; 
Anal. Calcd for C21H23O4P: C, 68.10; H, 6.26. Found: C, 68.37; 
H, 6.47; HRMS (ESI+): exact mass calcd for C21H23O4P [M+H]
+ 
requires m/z 371.1412, found m/z 371.1412. 
 
Diethyl (1-(2'-pyridyl)-2-naphthyl)phosphonate (4p) 
(Table 3, entries 9-10): 31P{1H} NMR (161.8 MHz, CDCl3, δ): 
18.5; 1H NMR (400 MHz, CDCl3, δ):  8.77 (d, J = 4.9 Hz, 1H, 
C5H4N), 8.06 (dd, J = 11.8, 8.5 Hz, 1H, C10H6P), 7.98 (dd, J = 
8.6, 3.8 Hz, 1H, C10H6P), 7.91 (d, J = 8.2 Hz, 1H, C10H6P), 7.84 
(td, J = 7.7, 1.8 Hz, 1H, C5H4N), 7.58–7.53 (m, 2H, C10H6P, 
C6H4N), 7.43–7.39 (m, 2H, C10H6P, C6H4N), 7.33 (d, J = 8.5 Hz, 
1H, C10H6P), 4.06–3.91 (br m, 4H, OCH2CH3), 1.19 (t, J = 6.9 
Hz, 6H, OCH2CH3); 
13C{1H} NMR (100.5 MHz, CDCl3, δ): 
157.6 (d, J = 5.9 Hz, C5H4N Q), 148.9 (C5H4N), 143.8 (d, J = 10.1 
Hz, C10H6P Q), 135.9 (C5H4N), 135.3 (d, J = 2.5 Hz, C10H6P Q), 
132.5 (d, J = 15.9 Hz, C10H6P Q), 128.3 (d, J = 23.8 Hz, C10H6P), 
128.3 (C5H4N), 128.1 (C5H4N), 128.1, 127.1, 127.1, 126.4 
(C10H6P), 124.4 (d, J = 186 Hz, C10H6P CP), 122.8 (C10H6P), 62.0 
(d, J = 5.6 Hz, OCH2CH3), 16.3 (d, J = 4.4 Hz, OCH2CH3); Mp: 
97–99oC; IR (neat, cm-1) = 1239, 1047, 1017, 960, 782, 747, 656, 
565; Anal. Calcd for C19H20NO3P: C, 66.85; H, 5.91; N, 4.10. 
Found: C, 67.23; H, 6.13; N, 4.41; HRMS (ESI+): exact mass 
calcd for C19H21O3NP [M+H]
+ requires m/z 342.1259, found m/z 
342.1257. 
 
2-(2ʹ-Methoxy-1ʹ-naphthyl)phenyl-1-phosphine (rac-6). A 
flame-dried Schlenk flask was cooled to room temperature under 
vacuum, backfilled with nitrogen and charged with LiAlH4 (0.041 
g, 1.08 mmol) and THF (4 mL). The mixture was then cooled to -
78 oC, chlorotrimethylsilane (0.14 mL, 1.08 mmol) added, 
resulting solution allowed to warm to RT over 30 min then re-
cooled to -78 oC and 2-methoxy-1-(2ʹ-
diethoxyphosphorylphenyl)naphthylene (0.133 g, 0.359 mmol)  in 
THF (4 mL) added. The resulting reaction mixture was allowed to 
warm to RT and stirred for 16 h after which degassed water (10 
mL) was added and the product extracted with degassed Et2O (2 × 
15 mL). The organic fractions were then combined, washed with 
water, dried over MgSO4, filtered and the solvent removed in 
vacuo to give the product as a white solid (0.093 g, 98 %). 
31P{1H} NMR (161.8 MHz, CDCl3, δ):  -127.8 (t, 
3JP-H = 204 Hz); 
1H NMR (400 MHz, CDCl3, δ): 7.94 (d, J = 9.0 Hz, 1H, 
C10H6OCH3), 7.87–7.85 (m, 1H, C6H4P), 7.73 (t, J = 7.1 Hz, 1H, 
C6H4P), 7.44 (t, J = 7.5 Hz, 1H, C6H4P), 7.39 (d, J = 9.1 Hz, 1H, 
C10H6OCH3), 7.38–7.34 (m, 3H, C10H6OCH3), 7.27–7.23 (m, 2H, 
C10H6OCH3, C6H4P), 3.89 (s, 3H, OCH3),  3.59 (dd, 
3JP-H = 204 
Hz, 1JH-H = 12.3 Hz, 1H, PH), 3.54 (dd, 
3JP-H = 204 Hz, 
1JH-H = 
12.3 Hz, 1H, PH); 13C{1H} NMR (100.5 MHz, CDCl3, δ): 153.8 
 (C10H6OCH3 Q), 141.1 (d, J = 14.0 Hz, C6H4P Q), 135.2 (d, J = 
11.3 Hz, C6H4P Q), 133.3 (C10H6OCH3 Q), 131.1 (d, J = 2.7 Hz, 
C6H4P), 130.1 (d, J = 212 Hz, C10H6OCH3 CP), 129.8 
(C10H6OCH3), 128.4 (C6H4P), 128.1 (C10H6OCH3), 127.5 (d, J = 
4.0 Hz, C6H4P), 126.8 (C10H6OCH3), 124.9 (C10H6OCH3), 124.6 
(d, J = 3.2 Hz, C10H6OCH3 Q), 123.8 (C10H6OCH3), 113.5 
(C10H6OCH3), 56.7 (OCH3); IR (neat, cm
-1) 1258, 1069, 1010, 
783; HRMS (ESI+): exact mass calcd for C17H15OP [M+H]
+ 
requires m/z 266.0861, found m/z 266.0863.     
 
1-[2-(2ʹ-Methoxy-1ʹ-napthyl)phenyl]-2,5-
dimethylphospholanium-1-yl](trihydrido)borate (7). 2-(2ʹ-
methoxy-1ʹ-naphthyl)phenyl-1-phosphine (0.093 g, 0.349 mmol) 
dissolved in degassed THF (20 mL) was cooled to -78 oC and 
nBuLi (2.5 M in hexanes, 0.15 mL, 0.384 mmol) was added 
dropwise.  The solution was then allowed to warm to RT and 
stirred at this temperature for 1 h.  A solution of (2S,5S)-2,5-
hexanediol cyclic sulphate (0.069 g, 0.383 mmol) in THF (10 mL) 
was then added at RT and stirred until the dark red solution 
decolourised to pale yellow (2 h).  The solution was cooled to -78 
oC and nBuLi (2.5 M in hexanes, 0.15 mL, 0.384 mmol) added 
dropwise. The solution was allowed to warm to RT and was 
stirred again until the dark red solution decolourised to pale 
yellow (20 h).  The solution was cooled again to -78oC and nBuLi 
(2.5 M in hexanes, 0.15 mL, 0.384 mmol) added dropwise. The 
solution was allowed to warm to RT and then stirred at this 
temperature for 36 h.  BH3.THF solution (0.70 mL, 0.698 mmol) 
was then added at 0oC and the solution stirred at RT for 16 h.  
H2O (10 mL) was then added and the solvent removed under 
reduced pressure.  The residue was extracted with Et2O (3 × 15 
mL), the organics combined, washed with H2O (10 mL), dried 
over MgSO4, filtered and the solvent removed in vacuo.  The 
crude product was purified by column chromatography eluting 
with petrol/EtOAc (5:1) to give the product as a white solid 
(0.033 g, 26 %). 11B NMR (128.3 MHz, CDCl3, δ): -39.6 (d, 
3JP-B 
= 49.4 Hz); 31P{1H} NMR (161.8 MHz, CDCl3, δ): 40.7 (br m); 
1H NMR (400 MHz, CDCl3, δ): a 1:1 mixture of diastereoisomers 
8.11–7.90 (m, 4H, C10H6OCH3 + C6H4P), 7.84–7.81 (m, 2H, 
C10H6OCH3), 7.58–7.50 (m, 4H, C6H4P), 7.34–7.30 (m, 6H, 
C10H6OCH3), 7.23–7.18 (m, 2H, C6H4P), 7.15–7.08 (m, 2H, 
C10H6OCH3), 3.84 (d, J = 1.8 Hz, 6H, OCH3), 2.22–2.11 (m, 2H, 
PCH), 1.94–1.81 (m, 2H,  PCH), 1.63–1.50 (m, 4H, CH2), 1.31–
1.12 (m, 2H, CH2), 1.00–0.88 (m, 6H, CH3), 0.49 (d, J = 6.6 Hz, 
3H, CH3), 0.47 (d, J = 6.7 Hz, 3H, CH3); 
13C{1H} NMR (100.5 
MHz, CDCl3, δ): a 1:1 mixture of diastereoisomers, 154.4 (C10H6 
Q), 153.7 (C10H6 Q), 141.8 (d, J = 6.0 Hz, Q), 141.4 (d, J = 2.7 
Hz, Q), 136.1, 135.0, 135.4, 135.3, 134.6 (Q), 134.4 (Q), 133.1 (d, 
J = 7.5 Hz), 132.8 (d, J = 6.8 Hz), 130.8 (d, J = 2.3 Hz), 130.7 (d, 
J = 2.0 Hz), 128.6 (d, J = 38.1 Hz, C6H4P CP), 128.6 (Q), 128.6 
(Q), 128.2, 128.0 (d, J = 37.0 Hz, C6H4P CP), 128.0, 127.5 (d, J = 
10.7 Hz), 127.2 (d, J = 9.5 Hz), 127.0, 126.6, 125.3, 125.1, 123.7, 
123.6 (d, J = 1.7 Hz, Q), 123.5, 123.2 (d, J = 2.4 Hz, Q), 112.7, 
112.5, 55.8 (OCH3) 36.8 (d, J = 37.2 Hz, CHCH3), 36.6 (d, J = 
37.6 Hz, CHCH3), 35.0 (2 × CH2), 34.2 (d, J = 5.8 Hz, CH2), 34.0 
(d, J = 5.4 Hz, CH2), 32.8 (d, J = 34.5 Hz, CHCH3), 31.5 (d, J = 
34.0 Hz, CHCH3), 15.6 (d, J = 2.9 Hz, CHCH3) 15.2 (d, J = 2.6 
Hz, CHCH3), 14.4 (d, J = 4.7 Hz, CHCH3), 13.7 (d, J = 4.6 Hz, 
CHCH3); IR (neat, cm
-1): 2929, 2370, 1265, 1065, 807, 730, 677; 
Anal. Calcd for C23H28BOP: C, 76.26; H, 7.79. Found: C, 76.58; 
H, 8.11; HRMS (ESI+): exact mass calcd for C23H28BOP [M+Na]
+ 
requires m/z 385.1869, found m/z 385.1857.   
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Sanz, R. Org. Lett. 2011, 13, 4970‒4973. 
(11) For synthesis via organolithium or Grignard reagents see: (a) 
Wolfe, J. P.; Singer, R. A.; Yang, B. H.; Buchwald, S. L. J. Am. Chem. 
Soc. 1999, 121, 9550‒9561. (b) Fox, J. M.; Huang, X.; Chieffi, A.; 
Buchwald, S. L. J. Am. Chem. Soc. 2000, 122, 1360‒1370. (c) Stambuli, J. 
P.; Stauffer, S. R.; Shaughnessy, K. H.; Hartwig, J. F. J. Am. Chem. Soc. 
2001, 123, 2677‒2678. (d) Ullah, E.; McNulty, J.; Robertson, A. Eur. J. 
Org. Chem. 2012, 2127‒2131. For metal catalysed C-P formation see: (e) 
Buchwald, S. L.; Murata, M. Tetrahedron 2004, 60, 7397‒7403. (f) 
Gelman, D.; Lei, J.; Buchwald, S. L. Org. Lett. 2003, 5, 2315‒2318.  
(12) (a) Kaye, S.; Fox, J. M.; Hicks, F. A.; Buchwald, S. L. Adv. 
Synth. Catal. 2001, 343, 789‒794. (b) Tomori, H.; Fox, J. M.; Buchwald, 
S. L. J. Org. Chem. 2000, 65, 5334‒5334. (c) Hamada, T.; Chieffi, A.; 
Ahmen, J.; Buchwald, S. L. J. Am. Chem. Soc. 2002, 124, 1261‒1268.   
(13) (a) Ashburn, B. O.; Carter, R. G.; Zakharov, L. N. J. Am. 
Chem. Soc. 2007, 129, 9109‒9116 (b) Ashburn, B. O.; Carter, R. G. 
Angew. Chem. Int. Ed. 2006, 45, 6737‒6737. (c) Doherty, S.; Smyth, C. 
S.; Harrington, R. W.; Clegg, W. Organometallics 2009, 28, 5273‒5276.  
(14) (a) Kondoh, A.; Yorimitsu, H.; Oshima, K.  J. Am. Chem. Soc. 
2007, 129, 6996‒6997. (b) Nishida, G.; Noguchi, K.; Hirano, M.; Tanaka, 
K. Angew. Chem. Int. Ed. 2007, 46, 3951‒3954. (c) Nishida, G.; Noguchi, 
K.; Hirano, M.; Tanaka, K. Angew. Chem. Int. Ed. 2008, 47, 3410‒3413. 
(d) Garcia, L.; Roglans, A.; Laurent, R.; Majoral, J.-P.; Pla-Quintana, A.; 
Caminade, A.-M. Chem. Commun. 2012, 48, 9248‒9250. (e) Doherty, S.; 
Knight, J. G.; Smyth, C. H.; Harrington, R. W.; Clegg, W. Org. Lett. 
2007, 9, 4925‒4928. (f) Doherty, S.; Smyth, C. H.; Harrington, R. W.; 
Clegg, W. Organometallics 2008, 27, 4837‒4840. (g) Nishida, G.; Ogaki, 
S.; Yusa, Y.; Yokozawa, T.; Noguchi, K.; Tanaka, K. Org. Lett. 2008, 10, 
2849‒2852.  
(15) (a) Doherty, S.; Knight, J. G.; Smyth, C. H.; Jorgensen, G. A. 
Adv. Synth. Catal. 2008, 350, 1801‒1806. (b) Doherty, S.; Knight, J. G.; 
McGrady, J. P.; Ferguson, A. M.; Ward, N. A. B.; Harrington R. W.; 
Clegg, W. Adv. Synth. Catal. 2010, 352, 201‒211. (c) Doherty, S.; Smyth, 
C. H.; Knight, J. G.; Hashmi, A. S. K. Nature Protocols 2012, 7, 1870‒
1883. (d) Doherty, S.; Knight, J. G.; Hashmi, A. S. K.; Smyth, C. H.; 
Ward, N. A. B.; Robson, K. J.; Tweedly, S.; Harrington, R. W.; Clegg, W. 
Organometallics, 2010, 29, 4139‒4147. (e) Hashmi, A. S. K.; Loos, A. 
Littmann, A.; Braun, I.; Knight, J. G.; Doherty, S.; Rominger, F. Adv. 
Synth. Catal. 2009, 351, 576‒582. (f) Hashmi, A. S. K.; Loos, A.; 
Doherty, S.; Knight. J. G.; Robson, K. J.; Rominger, F. Adv. Synth. Catal. 
2011, 353, 749‒759. (g) Doherty, S.; Knight, J. G.; Addyman, C. R.; 
Smyth, C. H.; Ward, N. A. N., Harrington, R. W. Organometallics 2011, 
30, 6010‒6016. 
(16) Kondoh, A.; Yorimitsu, H.; Oshima, K. Org. Lett. 2010, 12, 
1476‒1479.   
(17) Baillie, C.; Xiao, J. Tetrahedron 2004, 60, 4159‒4168. 
(18) (a) Yin, J. Y. Buchwald, S. L. J. Am. Chem. Soc. 2000, 122, 
12051‒12052. (b) Shen, X.; Jones, G. O.; Watson, D. A.; Bhayana, B.; 
Buchwald, S. L. J. Am. Chem. Soc. 2010, 132, 11278‒11285. (c) Tang, 
W.; Patel, N. D.; Xu, G.; Xu, X.; Savoie, J.; Ma, S.; Hao, M.-H.; 
Keshipeddy, S.; Capacci, A. G.; Wei, X.; Zhang, Y.; Gao, J. J.; Li, W.; 
Rodriguez, S.; Lu, B. Z.; Yee, N. K.; Senanayake, C. H. Org. Lett. 2012, 
14, 2258‒2261. (d) Wang, S.; Li, J.; Miao, T.; Wu, W.; Li, Q.; Zhuang, 
Y.; Zhou, Z.; Qiu, L. Org. Lett. 2012, 14, 1966‒1969. (e) Wu, W.; Wang, 
S.; Zhou, Y.; He, Y.; Zhuang, Y.; Li, L.; Wan, P.; Wang, L.; Zhou, Z.; 
Qiu, L. Adv. Synth. Catal. 2012, 354, 2395‒2402. (f) Yamamoto, T.; Akai, 
Y.; Nagata, Y.; Suginome, M. Angew. Chem. Int. Ed. 2011, 50, 8844‒
8847. (g) Zhou, Y.; Wang, S.; Wu, W.; Li, Q.; Zhuang, Y.; Li, L.; Pang, 
J.; Zhou, Z.; Qiu, L. Org. Lett. 2013, 15, 5508‒5513.  
(19) (a) Taylor, A. M.; Altman, R. A.; Buchwald, S. L. J. Am. 
Chem. Soc. 2009, 131, 9900‒9901. (b) Chieffi, A.; Kamikawa, K.; 
Ahman, J.; Fox, J. M.; Buchwald, S. L. Org. Lett. 2001, 3, 1897‒1900.  
(20) Hayashi, T.; Han, J. W.; Takeda, J.; Tang, K.; Nohmi, K.; 
Mukaide, K.; Tsuji, H.; Uozumi, Y. Adv. Synth. Catal. 2001, 343, 279‒
283.  
(21) Saha, B.; Rajambabu, T. V. J. Org. Chem. 2007, 72, 2357‒
2363.  
(22) Pereira, M. M.; Calvete, M. J. F.; Carrilho, R. M. B.; Abreu, A. 
R. Chem. Soc. Rev. 2013, 42, 6990‒7027.  
(23) V. Bhat, S. Wang, B. M. Stolz and S. C. Virgil, J. Am. Chem. 
Soc. 2013, 135, 16829‒16832.  
(24) Zhou, Q.-L. Privileged Chiral Ligands and Catalysts; Wiley-
VCH, Weinheim, 2011.  
(25) (a) Albert, J.; D’Andrea, L.; Granell, J.; Zafrilla, J.; Font-
Bardia, M.; Solans, X. J. Organomet. Chem. 2007, 691, 4895‒4902. (b) 
Albert, J.; Granell, J., Zafrilla, J.; Font-Bardia, M.; Solans, X. J. 
Organomet. Chem. 2005, 690, 422‒429. 
(26) Buchwald has recently introduced a third generation 
phosphine-ligated methanesulfonate-based palladacyclic precatalyst which 
can be prepared in high yield on a large scale via a straightforward 
procedure. (a) Bruno, M. C.; Buchwald, S. L. Org. Lett. 2013, 15, 2876-
2879. (b) Bruno, M. C.; Tudge, M. T.; Buchwald, S. L. Chem. Sci. 2013, 
4, 916-920.  
(27)  (a) Biscoe, M. R.; Fors, B. P.; Buchwald, S. L. J. Am. Chem. 
Soc. 2008, 130, 6686‒6687. (b) Kinzel, T.; Zhang, Y.; Buchwald, S. L. J. 
Am. Chem. Soc. 2010, 132, 14073‒14075. (c) Bruno, N. C.; Tudge, M. T.; 
Buchwald, S. L. Chem. Sci. 2013, 4, 916‒920. (d) Bruno, N. C.; 
Buchwald, S. L. Org. Lett. 2013, 15, 2876‒3879. 
(28) (a) Sajith, P. K.; Suresh, C. H. Dalton Trans. 2010, 39, 815‒
822. (b) Ros, A.; Estepa, B.; Ramírez-López, P.; Eleuterio, A.; Fernández, 
R.; Lassaletta, J. M. J. Am. Chem. Soc. 2013, 135, 15730‒15733.  
(29) König, M.; Reith, L. M.; Monkowius, U.; Knör, G.; 
Brettarbauer, K.; Schoefberger, W. Tetrahedron 2011, 67, 4243‒4252.  
(30) Doherty, S.; Knight, J. G.; Ward, N. A. B.; Bittner, D. M.; 
Wills, C.; McFarlane, Clegg, W.; Harrington, R. W. Organometallics 
2013, 32, 1773‒1788.   
(31)  (a) Lou, S.; Fu, G. C. Adv. Synth. Catal. 2010, 352, 2081‒
2084. (b) Kudo, N.; Perseghini, M.; Fu, G. C. Angew. Chem. Int. Ed. 
2006, 45, 1282‒1284; Angew. Chem. 2006, 18, 1304‒1306.      
(32) (a) Murata, M.; Oyama, T.; Watanabe, S.; Masuda, Y. J. Org. 
Chem. 2000, 65, 164‒168. (b) Ishiyama, T.; Ishida, K.; Miyaura, N. 
Tetrahedron 2001, 57, 9813‒9816. 
(33) (a) Fleckenstein, C. A.; Plenio, H. J. Org. Chem. 2008, 73, 
3236–3244. (b) Molander, G. A.; Canturk, B.; Kennedy, L. E. J. Org. 
Chem. 2009, 74, 973-980.     
(34) (a) Burk, M. J. J. Am. Chem. Soc. 1991, 113, 8518‒8519. (b) 
Burk, M. J.; Feaster, J. E.; Harlow, R. L. Tetrahedron: Asymmetry 1991, 
2, 569‒592.  
(35) Eaborn, C.; Golborn, P.; Spillett, R. E.; Taylor, R. J. Chem. 
Soc. (B), 1968, 1112‒1123.  
(36) Malkov, A. V.; Ramírez-López, P.; Biedermannová, L.; 
Rulíšek, L.; Dufková, L.; Kotora, M.; Zhu, F.; Kočovský, P. J. Am. Chem. 
Soc. 2008, 130,  5341‒5348.  
(37) Nataro, C.; Fosbenner, S. M. J. Chem. Ed. 2009, 86, 1412‒
1415.  
 
 
 
 
 
 
 
  
12 
 
 
 
Table of Contents Artwork 
 
